Business Description
Merit Medical Systems Inc
NAICS : 339112
SIC : 3841
ISIN : US5898891040
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.67 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.7 | |||||
Debt-to-EBITDA | 3.53 | |||||
Interest Coverage | 6.26 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.19 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 28 | |||||
3-Year EPS without NRI Growth Rate | 53.7 | |||||
3-Year FCF Growth Rate | -3.9 | |||||
3-Year Book Growth Rate | 6.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 10.77 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.42 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 76.96 | |||||
9-Day RSI | 73.61 | |||||
14-Day RSI | 69.01 | |||||
6-1 Month Momentum % | 3.32 | |||||
12-1 Month Momentum % | -14.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.03 | |||||
Quick Ratio | 4.38 | |||||
Cash Ratio | 3.17 | |||||
Days Inventory | 160.25 | |||||
Days Sales Outstanding | 49.35 | |||||
Days Payable | 30.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | -7.8 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.54 | |||||
Operating Margin % | 10.51 | |||||
Net Margin % | 7.94 | |||||
FCF Margin % | 10.18 | |||||
ROE % | 8.43 | |||||
ROA % | 5.11 | |||||
ROIC % | 7.36 | |||||
ROC (Joel Greenblatt) % | 18.46 | |||||
ROCE % | 7.91 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 46.19 | |||||
Forward PE Ratio | 24.26 | |||||
PE Ratio without NRI | 32.19 | |||||
Shiller PE Ratio | 103.63 | |||||
Price-to-Owner-Earnings | 44.83 | |||||
PEG Ratio | 2.66 | |||||
PS Ratio | 3.65 | |||||
PB Ratio | 3.79 | |||||
Price-to-Tangible-Book | 8.68 | |||||
Price-to-Free-Cash-Flow | 36.15 | |||||
Price-to-Operating-Cash-Flow | 28.29 | |||||
EV-to-EBIT | 35 | |||||
EV-to-EBITDA | 20.17 | |||||
EV-to-Forward-EBITDA | 16.58 | |||||
EV-to-Revenue | 3.89 | |||||
EV-to-Forward-Revenue | 3.77 | |||||
EV-to-FCF | 38.18 | |||||
Price-to-Projected-FCF | 2.52 | |||||
Price-to-DCF (Earnings Based) | 1.77 | |||||
Price-to-DCF (FCF Based) | 3.13 | |||||
Price-to-Median-PS-Value | 1.25 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.08 | |||||
Price-to-Graham-Number | 3.52 | |||||
Price-to-Net-Current-Asset-Value | 244.94 | |||||
Earnings Yield (Greenblatt) % | 2.86 | |||||
FCF Yield % | 2.78 | |||||
Forward Rate of Return (Yacktman) % | 17.23 |